Lukasiewicz S,Czeczelewski M,Forma A,Baj J,Sitarz R,Stanisławek A. Breast,Cancer-Epidemiology A. Breast .2021 .Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel), 10(17) : 4287.
Waks AG,Winer EP .2018 .Breast Cancer Treatment: A Review. JAMA, 10(3) : 288-300.
Yao K,Sisco M,Bedrosian I. .2016 .Contralateral prophylactic mastectomy: current perspectives. Int J Womens Health, 10 : 213-223.
Scheepens JCC,Esserman L,Belkora J,Mukhtar RA .2021 .Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability. Breast, 02 : 61-69.
You Q,Chen K,Li Y,Lai J,Fang Y,Shen S .2018 .Factors associated with the increasing trend of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ: Analysis of Surveillance, Epidemiology, and End Results data. Breast, 05 : 147-155.
Tuttle TM,Jarosek S,Habermann EB,Arrington A,Abraham A,Morris TJ .2008 .Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol, 20(9) : 1362-1367.
Jia Z,Li J,Zhang Y,Wang X,Xing J,Xing Z .2021 .Contralateral riskreducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis. Cancer Cell Int, 10(1) : 512.
Fayanju OM,Stoll CRT,Fowler S,Colditz GA,Margenthaler JA .2014 .Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg, 10(6) : 1000-1010.
Page MJ,McKenzie JE,Bossuyt PM,Boutron I,Hoffmann TC,Mulrow CD .2021 .The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 10 : .
Wells G,Shea B,O'Connell D,Peterson J,Welch V,Losos M .2023 .The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed November 18, : .
Egger M,Davey Smith G,Schneider M,Minder C. .1997 .Bias in meta-analysis detected by a simple, graphical test. BMJ, 10(7109) : 629-634.
Wu P,Chang H,Wang Q,Shao Q,He D. .2023 .Trends in metaplastic breast cancer incidence and mortality, and the effect of contralateral prophylactic mastectomy: A population-based study. Asian J Surg, 09(1) : 394-401.
Huang H,Wei T,Zhang A,Zhang H,Kong L,Li Y .2023 .Comparison of Survival Outcomes in Young Patients With Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy. Clin Breast Cancer, 07(7) : 752-762.
Fasano GA,Bayard S,Chen Y,Marti J,Simmons R,Swistel A .2023 .Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy. Ann Surg Oncol, 10(8) : 4648-4656.
Makhnoon S,Gutierrez Barrera AM,Bassett R,Afrough A,Bedrosian I,Arun BK,Differences Ethnic .2022 .Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival. Breast J, 10 : .
Yang P. Contralateral Prophylactic .2021 .6. Clin Oncol, 900438 : .
Chen H,Zhang P,Zhang M,Wang M,Bai F,Wu K .2019 .Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer. J Surg Res, 02 : 224-232.
Lazow SP,Riba L,Alapati A,James TA .2019 .Comparison of breastconserving therapy vs mastectomy in women under age 40: National trends and potential survival implications. Breast J, 10(4) : 578-584.
Wong SM,Freedman RA,Sagara Y,Aydogan F,Barry WT,Golshan M. Growing .2017 .Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg, 10(3) : 581-589.
Heemskerk-Gerritsen BAM,Rookus MA,Aalfs CM,Ausems MGEM,Collée JM,Jansen L .2015 .Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer, 10(3) : 668-677.
Pesce C,Liederbach E,Wang C,Lapin B,Winchester DJ,Yao K. .2014 .Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer. Ann Surg Oncol, 10(10) : 3231-3239.
Jatoi I,Parsons HM .2014 .Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Res Treat, 10(2) : 389-396.
Metcalfe K,Gershman S,Ghadirian P,Lynch HT,Snyder C,Tung N .2014 .Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ, 10 : .
Evans DGR,Ingham SL,Baildam A,Ross GL,Lalloo F,Buchan I .2013 .Contralateral mastectomy improves survival in women with BRCA1/2- associated breast cancer. Breast Cancer Res Treat, 10(1) : 135-142.
Yao K,Winchester DJ,Czechura T,Huo D. .2013 .Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base,. Breast Cancer Res Treat, 10(3) : 465-476.
Brewster AM,Bedrosian I,Parker PA,Dong W,Peterson SK,Cantor SB .2012 .Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer, 10(22) : 5637-5643.
King TA,Sakr R,Patil S,Gurevich I,Stempel M,Sampson M .2010 .Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol, 29(16) : 2158-2164.
Kiely BE,Jenkins MA,McKinley JM,Friedlander ML,Weideman P,Milne RL .2010 .Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Breast Cancer Res Treat, 10(3) : 715-723.
Bedrosian I,Hu CY,Chang GJ .2010 .Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst, 10(6) : 401-409.
Boughey JC,Hoskin TL,Degnim AC,Sellers TA,Johnson JL,Kasner MJ .2010 .Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol, 10(10) : 2702-2709.
Van Sprundel TC,Schmidt MK,Rookus MA,Brohet R,Van Asperen CJ,Rutgers EJT .2005 .Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer, 10(3) : 287-292.
Herrinton LJ,Barlow WE,Yu O,Geiger AM,Elmore JG,Barton MB .2005 .Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol, 10(19) : 4275-4286.
Rosenberg SM,Sepucha K,Ruddy KJ,Tamimi RM,Gelber S,Meyer ME .2015 .Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol, 10(12) : 3809-3815.
Ager B,Butow P,Jansen J,Phillips KA,Porter D .2016 .Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfaction. Breast, 04 : 107-120.
Fei G,Yan W,Yao H .2023 .Effect of single intravenous injection of esketamine on quality of recovery during early period after modified radical mastectomy for breast cancer: A retrospective study. Pak J Med Sci, 10(6) : 8057-1767.